O. Ozdogan Et Al. , "Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?," GASTROENTEROLOGY , vol.112, no.4, 1997
Ozdogan, O. Et Al. 1997. Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?. GASTROENTEROLOGY , vol.112, no.4 .
Ozdogan, O., Goren, Z., Tozun, N., Moini, H., Bilsel, S., Celikel, C., ... Kalayci, C.(1997). Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?. GASTROENTEROLOGY , vol.112, no.4.
Ozdogan, O Et Al. "Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?," GASTROENTEROLOGY , vol.112, no.4, 1997
Ozdogan, O Et Al. "Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?." GASTROENTEROLOGY , vol.112, no.4, 1997
Ozdogan, O. Et Al. (1997) . "Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?." GASTROENTEROLOGY , vol.112, no.4.
@article{article, author={O Ozdogan Et Al. }, title={Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?}, journal={GASTROENTEROLOGY}, year=1997}